India's Bharat Biotech plans global launch for its oral cholera vaccine Hillchol

Bharat Biotech nasal vaccine price and launch date revealed! Know how does a nasal vaccine work

India: Bharat Biotech’s nasal Covid vaccine to be available as booster dose on CoWIN app now

Covaxin booster offers long-term protection against severe Covid infection: Bharat Biotech

Omicron threat: Covaxin maker Bharat Biotech studying if vaccine works against variant

India's Covaxin to be added to UK approved list from November 22

Approval sought in US for India-made Covaxin's use on those aged 2 to 18

Bharat Biotech's Covid vaccine Covaxin gets emergency use listing from WHO panel

Delayed again: WHO seeks more 'clarifications' on made-in-India Covid shot Covaxin

The World Health Organization (WHO) seeks 'additional clarifications' from Bharat Biotech for Covaxin to conduct a final 'risk-benefit assessment' for emergency use listing of the vaccine.

No WHO approval for Bharat Biotech' Covaxin as panel wants more details

One billion COVID-19 vaccine doses: Bharat Biotech chairman lauds govt; terms it significant feat

The subject expert committee of India's drug regulator is all set to take a call on Bharat Biotech’s pediatric COVID vaccine. Bharat biotech, which completed its phase-ii and iii trials of Covaxin's pediatric jab has submitted the data to the central drugs standard control organization for its verification and subsequent approval.

India's drug regulator all set to take call on Bharat Biotech’s pediatric COVID vaccine

Bharat Biotech terminates Covaxin deal with Brazil after graft allegations

Bharat Biotech's partner seeks approval for India-made Covaxin in Canada

Bharat Biotech said that it has concluded the final analysis for its COVID-19 vaccine Covaxin as part of phase-3 clinical trials. The Hyderabad-based pharma company claimed that its indigenous jab demonstrates an overall efficacy of 77.8% against symptomatic infection.

Bharat Biotech announces Covaxin's efficacy rate after final stage trials

As calls grow for his impeachment, Bolsonaro fires official over graft claims

India's home-made shot Covaxin is at the centre of a storm in Brazil. Federal prosecutors in Brazil suspect corruption in the way Bharat Biotech's representative reached an agreement with the government. Palki Sharma tells you more.

Gravitas: Covaxin at the centre of a storm in Brazil

Brazil prosecutors probe price, intermediary on Bharat Biotech vaccine deal

COVID-19: Bharat Biotech's pre-submission meeting for Covaxin's WHO approval on June 23

Ahead of WHO-Bharat Biotech meet on Covaxin, key stakeholders come together

Bharat Biotech applies for WHO nod for Covaxin; pre-submission meeting soon

Exclusive: Bharat Biotech's Joint MD Suchitra Ella confident on Covid vaccine production commitments

Suchitra Ella, joint managing director of Bharat Biotech has expressed confidence on meeting commitments that have been "made to govt of India", with the company aiming to produce 1 billion COVID vaccine COVAXIN doses involving facilities in Hyderabad, Bangalore, and Ankleshwar. Ella co-founded the company along with Dr Krishna M Ella and its COVID vaccine along with Covishield and sputnik are the only 3 vaccines allowed in India.

Bharat Biotech's Suchitra Ella confident on vaccine production commitments

India's expert panel recommends Covaxin trials on 2-18 year-olds

As per the official sources, the trial for the vaccine will take place in 525 subjects at different sites, including AIIMS, Patna, AIIMS, Delhi, and Meditrina Institute of Medical Sciences, Nagpur.

Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old

Bharat Biotech reduces price of Covaxin for Indian state governments

Indian Govt asks Serum Institute, Bharat Biotech to lower price of COVID-19 vaccines: Official sources  

Bharat Biotech prices Covaxin at Rs 600 for states, Rs 1,200 for pvt hospitals  

The Indian vaccine manufacturer Bharat Biotech has released its amended prices as the country aims to open up vaccination drive to all adults from 1 May.

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination

Covaxin has an efficacy of 78% against severe Covid-19 cases: Bharat BioTech

Bharat Biotech has announced the Phase 3 clinical trial results for its Coronavirus vaccine candidate Covaxin. The company said that Covaxin demonstrated an efficacy of 81 per cent in the trials.

Bharat Biotech announces successful Phase-3 trial results of Covaxin

Participants received a vaccine or placebo in a 1:1 ratio, which showed that the vaccine candidate was well tolerated, said the company

Covaxin showed 81% efficacy against UK variant

Bharat Biotech's Covaxin found 81% efficient in Phase 3 trials

According to reports, Chinese hacking groups are targeting Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech. Both SII and Bharat Biotech are involved in producing the COVID-19 vaccine.

Report: Hackers target Indian vaccine makers SII, Bharat Biotech

Brazil signs deal with India's Bharat Biotech for 20 million Covid-19 vaccine doses

India has exported vaccines worth Rs 338 crore: Government declares in Parliament

According to a new study, India's homegrown jab Covaxin is likely to be effective against the UK variant of the Coronavirus. Covaxin is developed by Bharat Biotech, it has been approved for emergency use by India's drug regulators.

Study: Covaxin developed by Indian Pharma firm Bharat Biotech neutralizes UK variant

GSK to move malaria vaccine production to India's Bharat Biotech

Bharat Biotech's COVID-19 shot safe, produced immune response in early human trial: Study

India's Bharat Biotech seeks emergency use approval for vaccine in Philippines

Gap of 28 days between two Covid vaccine doses, effectiveness to begin after 14 days: Government

Coronavirus vaccine arrives in Hyderabad; Gujarat, Tamil Nadu set to receive consignment

Bill Gates and other world leaders applaud India for quick vaccine production

Expert panel recommends India's indigenously developed Covid-19 vaccine Covaxin for restricted emergency use

Brazil's private clinics seek India's COVAXIN vaccine

Indian Government to approve their vaccine called COVAXIN by Bharat Biotech, this could be a game changer in fight against covid pandemic. The vaccine is currently on Phase 3rd trial.

Indian vaccine could be the game changer in fight against COVID-19

Covishield, Covaxin are safe and provide robust immune response, says Drug Controller General of India VG Somani

Pfizer-BioNTech requests more time, India's SEC to meet on January 1 to authorise SII, Bharat Biotech vaccines

Bharat Biotech recruits 13,000 volunteers for Phase III trials of Covaxin

bharat-biotech

https://www.wionews.com/tags/bharat-biotech.html, News on https://www.wionews.com/tags/bharat-biotech.html, stories on https://www.wionews.com/tags/bharat-biotech.html, articles on https://www.wionews.com/tags/bharat-biotech.html, https://www.wionews.com/tags/bharat-biotech.html stories at Wion, https://www.wionews.com/tags/bharat-biotech.html news, https://www.wionews.com/tags/bharat-biotech.html latest news

bharat biotech

India's Bharat Biotech plans global launch for its oral cholera vaccine Hillchol

Bharat Biotech nasal vaccine price and launch date revealed! Know how does a nasal vaccine work

India: Bharat Biotech’s nasal Covid vaccine to be available as booster dose on CoWIN app now

Covaxin booster offers long-term protection against severe Covid infection: Bharat Biotech

Omicron threat: Covaxin maker Bharat Biotech studying if vaccine works against variant

India's Covaxin to be added to UK approved list from November 22

Approval sought in US for India-made Covaxin's use on those aged 2 to 18

Bharat Biotech's Covid vaccine Covaxin gets emergency use listing from WHO panel

Delayed again: WHO seeks more 'clarifications' on made-in-India Covid shot Covaxin

No WHO approval for Bharat Biotech' Covaxin as panel wants more details

No WHO approval for Bharat Biotech' Covaxin as panel wants more details

One billion COVID-19 vaccine doses: Bharat Biotech chairman lauds govt; terms it significant feat

India's drug regulator all set to take call on Bharat Biotech’s pediatric COVID vaccine

Bharat Biotech terminates Covaxin deal with Brazil after graft allegations

Bharat Biotech's partner seeks approval for India-made Covaxin in Canada

Bharat Biotech announces Covaxin's efficacy rate after final stage trials

As calls grow for his impeachment, Bolsonaro fires official over graft claims

Gravitas: Covaxin at the centre of a storm in Brazil

Brazil prosecutors probe price, intermediary on Bharat Biotech vaccine deal

COVID-19: Bharat Biotech's pre-submission meeting for Covaxin's WHO approval on June 23

Ahead of WHO-Bharat Biotech meet on Covaxin, key stakeholders come together

Bharat Biotech applies for WHO nod for Covaxin; pre-submission meeting soon

Exclusive: Bharat Biotech's Joint MD Suchitra Ella confident on Covid vaccine production commitments

Bharat Biotech's Suchitra Ella confident on vaccine production commitments